3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
5
Neoplasms
2
Solid Tumor, Adult
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Interventions
pembrolizumab
3
Cyclophosphamide
3
fludarabine
2
Rosuvastatin Calcium
2
Radiotherapy
2
Paclitaxel
2
Ipilimumab
2
Interleukin-2
2
Carboplatin
2
spartalizumab
1
peposertib
1
osimertinib
1
niraparib
1
neotil
1
necitumumab
1
mirdametinib
1
apatinib
1
amivantamab
1
Valganciclovir
1
Tomography, X-Ray Computed
1
Rifampin
1
Radiation
1
Positron-Emission Tomography
1
PankoMab-GEX
1
Panitumumab
1
Nivolumab
1
Midazolam
1
Metformin
1
Magnetic Resonance Imaging
1
MEK inhibitor I
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Solid Tumor, Adult
×
necitumumab
×
Clear all
NCT03360734
2021-07-12
GATTO
Glycotope GmbH
Phase 1
Completed
50 enrolled